ILF2 and esophageal cancer: Nicotine promotes the stabilization and expression of SALL4 by upregulating the RNA-binding protein interleukin enhancer binding factor 2 (ILF2), which facilitates tumor initiation in esophageal cancer cells (Li et al. 2021).